Table 2.
Clinic-pathological features or prognostic value of LINC00520 dysfunction.
| Tumor type | The expression of LINC00520 | Clinicopathological characteristics/Chemoresistance | Prognostic value | Ref. |
|---|---|---|---|---|
| Lung cancer | Up-regulation | Prognostic factor of OS | (11) | |
| PTC | Up-regulation | associated with tumor size, lymph node metastasis, and TNM stage | Prognostic factor of OS | (14) |
| CRC | Up-regulation | associated with tumor size, lymph node metastasis, and TNM stage | Prognostic factor of OS Prognostic factor of DFS | (15) |
| cSCC | Down-regulation | associated with tumor volumes, weights, and lymph node metastasis | (22) | |
| MM | Up-regulation | Prognostic factor of OS | (18) | |
| Up-regulation | associated with lymph node metastasis | Prognostic factor of OS | (16) | |
| LUAD | Up-regulation | Prognostic factor of OS | (13) | |
| HNSCC | Up-regulation | associated with radiosensitivity | (19) | |
| LSCC | Up-regulation | associated with lymph node metastasis | (20) |
PTC, papillary thyroid carcinoma; CRC, colorectal cancer; cSCC, cutaneous squamous cell carcinoma; MM, melanoma; LUAD, lung adenocarcinoma; HNSCC, head and neck squamous cell carcinoma; LSCC, laryngeal squamous cell carcinoma; OS, overal survivle; DFS, disease-free survival.